A 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated using Cytoreductive Surgery ...

Tamron Little was given 18 months to live after a delayed diagnosis of peritoneal mesothelioma. Now, 18 years later, she's ...

In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with ...

Low, clinically relevant doses of metformin lower blood glucose by inhibiting the Rap1 protein in specific neurons of the ...

HIPEC is an often-overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal ...

World Hepatitis Day is the global campaign organized annually on July 28 by the World Health Organization (WHO) to increase ...

In June 2025, Iovance Biotherapeutics announced that the Journal of Clinical Oncology has published the final analysis from ...

(Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the first patient has been dosed in the pivotal Phase 3 OVATION 3 Study ...

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), ...

This study provides novel and convincing evidence that both dopamine D1 and D2 expressing neurons in the nucleus accumbens shell are crucial for the expression of cue-guided action selection, a ...

The OVATION-3 trial is designed to provide an early readout in HRD and BRCA1/2-mutated ovarian cancer patients, ideally leading to rapid filing and approval.